Form 4: Qualys CLO Sells Shares Under 10b5-1 Plan

Qualys' Chief Legal Officer, Bruce K. Posey, sold 525 shares of common stock on August 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Bruce K. Posey, Chief Legal Officer of Qualys, Inc. (QLYS), reported the sale of 525 shares of common stock.
• The transactions occurred on August 20, 2025.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Posey on August 21, 2024.
• The shares were sold in three separate transactions at weighted average prices of $131.8922, $132.7383, and $133.618.
• Following these transactions, Mr. Posey directly beneficially owns 57,840 shares of Qualys common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be perceived negatively, the execution under a pre-arranged Rule 10b5-1 plan indicates a scheduled, non-discretionary transaction, which typically carries less negative signaling than an unannounced, opportunistic sale.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which indicates a scheduled transaction rather than a reactive one, mitigating the negative signal often associated with insider selling.

Negatives

• The Chief Legal Officer's direct beneficial ownership of Qualys common stock decreased by 525 shares.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in the reporting person's direct ownership, which is a routine disclosure for insider transactions. It does not directly impact other shareholders' holdings or the company's capital structure.

Key Dates

Recommendation

The filing details a routine insider stock sale conducted under a pre-arranged Rule 10b5-1 trading plan. This type of transaction is generally not indicative of a significant change in company fundamentals or future prospects, and therefore does not warrant a change in investment recommendation based solely on this disclosure.

Keywords

Qualys, QLYS, SEC Form 4, Insider Trading, Stock Sale, Bruce K. Posey, Chief Legal Officer, 10b5-1 Plan